Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (50)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Angata, T.
Right arrow Articles by Varki, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Angata, T.
Right arrow Articles by Varki, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Glycobiology, 2000, Vol. 10, No. 4 431-438
© 2000 Oxford University Press

Siglec-7: a sialic acid-binding lectin of the immunoglobulin superfamily

Takashi Angata and Ajit Varki1

Glycobiology Research and Training Center, Department of Medicine and Cancer Center, University of California San Diego, La Jolla, CA 92093, USA

The Siglecs are a recently discovered family of sialic acid-binding lectins of the immunoglobulin (Ig) superfamily. We report a molecule showing homology to the six first reported Siglecs, with the closest relationship to Siglec-3(CD33), Siglec-5, and Siglec-6(OBBP-1). The extracellular portion has two Ig-like domains, with the amino-terminal V-set Ig domain including amino acid residues known to be involved in sialic acid recognition by other Siglecs. The cytoplasmic domain has putative sites of tyrosine phos­phorylation shared with some Siglecs, including an Immuno­receptor Tyrosine-based Inhibitory Motif (ITIM). Expression of the full-length cDNA induces sialic acid-dependent binding to human erythrocytes. A recombinant chimeric form containing the extracellular Ig domains selectively recognizes the sequence Neu5Ac{alpha}2–6Galß1–4Glc, and binding requires the side chain of sialic acid. Mutation of an arginine residue predicted to be critical for sialic acid binding abolishes both interactions. Taken together, our findings justify designation of the molecule as Siglec-7. Analysis of bacterial artificial chromosome (BAC) clones spanning the known human genomic location of Siglec-3 indicates that the Siglec-7 gene is also located on chromosome 19q13.3–13.4. Human tissues show strong expression of Siglec-7 mRNA in spleen, peripheral blood leukocytes, and liver. The combination of an extracellular sialic acid binding site and an intracellular ITIM motif suggests that this molecule is involved in trans-membrane regulatory signaling reactions.

1 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
S. A. Hudson, N. V. Bovin, R. L. Schnaar, P. R. Crocker, and B. S. Bochner
Eosinophil-Selective Binding and Proapoptotic Effect in Vitro of a Synthetic Siglec-8 Ligand, Polymeric 6'-Sulfated Sialyl Lewis X
J. Pharmacol. Exp. Ther., August 1, 2009; 330(2): 608 - 612.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
T. Angata, Y. Tabuchi, K. Nakamura, and M. Nakamura
Siglec-15: an immune system Siglec conserved throughout vertebrate evolution
Glycobiology, August 1, 2007; 17(8): 838 - 846.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. J. Orr, N. M. Morgan, J. Elliott, J. F. Burrows, C. J. Scott, D. W. McVicar, and J. A. Johnston
CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover
Blood, February 1, 2007; 109(3): 1061 - 1068.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Attrill, A. Imamura, R. S. Sharma, M. Kiso, P. R. Crocker, and D. M. F. van Aalten
Siglec-7 Undergoes a Major Conformational Change When Complexed with the {alpha}(2,8)-Disialylganglioside GT1b
J. Biol. Chem., October 27, 2006; 281(43): 32774 - 32783.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
T. Angata, T. Hayakawa, M. Yamanaka, A. Varki, and M. Nakamura
Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates
FASEB J, October 1, 2006; 20(12): 1964 - 1973.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
A. Varki and T. Angata
Siglecs--the major subfamily of I-type lectins
Glycobiology, January 1, 2006; 16(1): 1R - 27R.
[Abstract] [Full Text] [PDF]

Home page
 J BiochemHome page
A. Tsuchida, M. Ogiso, Y. Nakamura, M. Kiso, K. Furukawa, and K. Furukawa
Molecular Cloning and Expression of Human ST6GalNAc III: Restricted Tissue Distribution and Substrate Specificity
J. Biochem., September 1, 2005; 138(3): 237 - 243.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Ikehara, S. K. Ikehara, and J. C. Paulson
Negative Regulation of T Cell Receptor Signaling by Siglec-7 (p70/AIRM) and Siglec-9
J. Biol. Chem., October 8, 2004; 279(41): 43117 - 43125.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Miyazaki, K. Ohmori, M. Izawa, T. Koike, K. Kumamoto, K. Furukawa, T. Ando, M. Kiso, T. Yamaji, Y. Hashimoto, et al.
Loss of Disialyl Lewisa, the Ligand for Lymphocyte Inhibitory Receptor Sialic Acid-Binding Immunoglobulin-Like Lectin-7 (Siglec-7) Associated with Increased Sialyl Lewisa Expression on Human Colon Cancers
Cancer Res., July 1, 2004; 64(13): 4498 - 4505.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
O. Blixt, B. E. Collins, I. M. van den Nieuwenhof, P. R. Crocker, and J. C. Paulson
Sialoside Specificity of the Siglec Family Assessed Using Novel Multivalent Probes: IDENTIFICATION OF POTENT INHIBITORS OF MYELIN-ASSOCIATED GLYCOPROTEIN
J. Biol. Chem., August 15, 2003; 278(33): 31007 - 31019.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
E. C. M. Brinkman-Van der Linden, T. Angata, S. A. Reynolds, L. D. Powell, S. M. Hedrick, and A. Varki
CD33/Siglec-3 Binding Specificity, Expression Pattern, and Consequences of Gene Deletion in Mice
Mol. Cell. Biol., June 15, 2003; 23(12): 4199 - 4206.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
B. E. Collins, O. Blixt, N. V. Bovin, C.-P. Danzer, D. Chui, J. D. Marth, L. Nitschke, and J. C. Paulson
Constitutively unmasked CD22 on B cells of ST6Gal I knockout mice: novel sialoside probe for murine CD22
Glycobiology, September 1, 2002; 12(9): 563 - 571.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Angata, S. C. Kerr, D. R. Greaves, N. M. Varki, P. R. Crocker, and A. Varki
Cloning and Characterization of Human Siglec-11. A RECENTLY EVOLVED SIGNALING MOLECULE THAT CAN INTERACT WITH SHP-1 AND SHP-2 AND IS EXPRESSED BY TISSUE MACROPHAGES, INCLUDING BRAIN MICROGLIA
J. Biol. Chem., June 28, 2002; 277(27): 24466 - 24474.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Grobe and L. D. Powell
Role of protein kinase C in the phosphorylation of CD33 (Siglec-3) and its effect on lectin activity
Blood, May 1, 2002; 99(9): 3188 - 3196.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Yamaji, T. Teranishi, M. S. Alphey, P. R. Crocker, and Y. Hashimoto
A Small Region of the Natural Killer Cell Receptor, Siglec-7, Is Responsible for Its Preferred Binding to alpha 2,8-Disialyl and Branched alpha 2,6-Sialyl Residues. A COMPARISON WITH Siglec-9
J. Biol. Chem., February 15, 2002; 277(8): 6324 - 6332.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Angata, N. M. Varki, and A. Varki
A Second Uniquely Human Mutation Affecting Sialic Acid Biology
J. Biol. Chem., October 19, 2001; 276(43): 40282 - 40287.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. M. Matsui, L. Borsig, S. D. Rosen, M. Yaghmai, A. Varki, and S. H. Embury
P-selectin mediates the adhesion of sickle erythrocytes to the endothelium
Blood, September 15, 2001; 98(6): 1955 - 1962.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Angata and A. Varki
Cloning, Characterization, and Phylogenetic Analysis of Siglec-9, a New Member of the CD33-related Group of Siglecs. EVIDENCE FOR CO-EVOLUTION WITH SIALIC ACID SYNTHESIS PATHWAYS
J. Biol. Chem., July 14, 2000; 275(29): 22127 - 22135.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Vinson, P. J. L. M. Strijbos, A. Rowles, L. Facci, S. E. Moore, D. L. Simmons, and F. S. Walsh
Myelin-associated Glycoprotein Interacts with Ganglioside GT1b. A MECHANISM FOR NEURITE OUTGROWTH INHIBITION
J. Biol. Chem., June 1, 2001; 276(23): 20280 - 20285.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Li, W. Zhang, T. Wan, J. Zhang, T. Chen, Y. Yu, J. Wang, and X. Cao
Cloning and Characterization of Siglec-10, a Novel Sialic Acid Binding Member of the Ig Superfamily, from Human Dendritic Cells
J. Biol. Chem., July 20, 2001; 276(30): 28106 - 28112.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. Yu, C.-M. Lai, M. Maoui, D. Banville, and S.-H. Shen
Identification and Characterization of S2V, a Novel Putative Siglec That Contains Two V Set Ig-like Domains and Recruits Protein-tyrosine Phosphatases SHPs
J. Biol. Chem., June 22, 2001; 276(26): 23816 - 23824.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Angata, R. Hingorani, N. M. Varki, and A. Varki
Cloning and Characterization of a Novel Mouse Siglec, mSiglec-F. DIFFERENTIAL EVOLUTION OF THE MOUSE AND HUMAN (CD33) Siglec-3-RELATED GENE CLUSTERS
J. Biol. Chem., November 21, 2001; 276(48): 45128 - 45136.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.